Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-29

Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis. [Phase 2]

View source ↗

Summary

A Phase 2 trial conducted by Abbott to evaluate the safety and effectiveness of Asoprisnil in women with endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asoprisnil (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Endometriosis | Phase 2 | Status: COMPLETED